Clinical Effects of Altered Biomechanics in Knee Osteoarthritis
Lateral wedge orthotic shoe inserts
+ Standard orthotic shoe inserts
Arthritis+2
+ Joint Diseases
+ Musculoskeletal Diseases
Treatment Study
Summary
Study start date: June 1, 2003
Actual date on which the first participant was enrolled.Osteoarthritis (OA) is a chronic disease causing deterioration of the joint cartilage and the formation of bone spurs at the margins of the joints. Knee OA causes substantial pain, suffering, and disability, as well as enormous economic burden on the patient; unfortunately, treatment provides relief but not a cure. The majority of patients with symptomatic knee OA do not attain satisfactory long-term relief, even with recent advances in pain relievers. Analgesic treatment may relieve the pain but does not improve biomechanics and may even aggravate OA. Although OA is complex and not completely understood, disease onset and progression are at least partly related to responses by bone and cartilage to biomechanical loading. Devices that promote pressure reduction from the medial knee may provide pain relief while simultaneously protecting the joint from further degeneration; one such device is a lateral wedge orthotic shoe insert. When worn during weight-bearing activity, these inserts have been shown to reduce loading of the medial compartment and may provide pain relief. This study will evaluate the effectiveness of orthotic shoe inserts in controlling and relieving knee OA. The study will also assess improvements in loading biomechanics of the knee. This is a 3-year study. Patients will be randomly assigned to one of two groups; the first group will receive lateral wedge orthotic inserts and the second group will receive standard orthotic inserts. There will be 10 study visits during the course of the study. Patients will undergo X-rays and bone mineral density testing (DEXA) and 3 blood collections during the course of the study.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.100 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Treatment Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Over 25 Years
Range of ages for which participants are eligible to join.Healthy volunteers allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Inclusion Criteria * Able and willing to give informed consent and to comply with the study protocol and follow-up instructions * Symptomatic and radiographic OA of the knee * Knee pain upon walking * Predominant medial compartment OA Exclusion Criteria * Knee flexion contracture of greater than 15 degrees or inability to walk without assistance * Predominant lateral compartment OA of either knee * Greater than 3 degree valgus or greater than 12 degree varus deformity of either knee, as defined by the mechanical axis * Clinically evident OA of the ankle or hip * Clinically significant intrinsic foot disease upon podiatric evaluation, including any foot condition that may be aggravated by wearing orthotics * Substantial obesity, defined as having body mass index (BMI) greater than 35 * Anticipation of surgery involving any joint of either lower extremity in the next 3 years * Habitual use of inappropriate shoewear that would interfere with adequate use of the orthotic inserts * Inflammatory arthropathy, such as rheumatoid arthritis, systemic lupus, or active gout * Chronic infection in any joint of the lower extremities * History of fracture of either lower extremity within 6 months of study entry * History of knee or hip arthroplasty or of surgical arthroscopy of either knee within 3 months of study entry * History of intra-articular injections (glucocorticoids or hyaluronic acid derivatives) in the index knee within 6 months of study entry * Pregnancy * Any medical condition which, in the opinion of the investigator, would render the patient unable to comply with the protocol
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.2 intervention groups are designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalGroup II
Active ComparatorStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location